Results 11 to 20 of about 358,075 (256)

Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis [PDF]

Patient Preference and Adherence, 2023
Alan Kivitz,1 Alicia M Ellis,2 Vishvesh Shende,3 Jérémy Lambert,4 Daljit Tatla2 1Altoona Center for Clinical Research, Duncansville, PA, USA; 2UCB Pharma, Raleigh, NC, USA; 3UCB Pharma, Slough, UK; 4UCB Pharma, Colombes, FranceCorrespondence: Daljit ...
Kivitz A, Ellis AM, Shende V, Lambert J, Tatla D   +4 more
doaj   +2 more sources

Factors associated with the acceptability of self-injection training by clients receiving DMPA-SC services from community pharmacies and patent and proprietary medicine vendors in Nigeria [PDF]

BMC Women's Health
Background The self-administration of the subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has the potential to empower women and improve contraceptive use. Several studies have demonstrated the acceptability of the provider-administered DMPA-SC,
Toyin O. Akomolafe, Emeka Emmanuel Okafor, Sikiru Baruwa, Osimhen Ubuane, Michael Alagbile, Delafrida Ukaga, Ijeoma Nwankwo, Rodio Diallo   +7 more
doaj   +2 more sources

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study [PDF]

BMC Neurology, 2010
Background Multiple sclerosis (MS) currently requires long-term treatment with disease-modifying drugs, administered parenterally up to once daily. The need for regular self-injection can be a barrier to treatment for many patients.
Verdun di Cantogno Elisabetta, Singer Barry, Lugaresi Alessandra, Lang Michael, Borre Björn, Arbizu Txomin, Devonshire Virginia, Cornelisse Peter   +7 more
doaj   +2 more sources

Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment. [PDF]

BMC Womens Health
Adefalu AA, Afolaranmi TO, Fontenot E, Simon R, Buba M, Dafe V, Olabode F, Ajayi M, Latunji O, Dogo JM.   +9 more
europepmc   +3 more sources

Correction: A chip-scale second-harmonic source via self-injection-locked all-optical poling. [PDF]

Light Sci Appl
Clementi M, Nitiss E, Liu J, Durán-Valdeiglesias E, Belahsene S, Debrégeas H, Kippenberg TJ, Brès CS.   +7 more
europepmc   +3 more sources

Adolescent and Youth Experiences With Contraceptive Self-Injection in Uganda: Results From the Uganda Self-Injection Best Practices Project. [PDF]

J Adolesc Health, 2023
Corneliess C, Cover J, Secor A, Namagembe A, Walugembe F.   +4 more
europepmc   +3 more sources

A chip-scale second-harmonic source via self-injection-locked all-optical poling. [PDF]

Light Sci Appl, 2023
Clementi M, Nitiss E, Liu J, Durán-Valdeiglesias E, Belahsene S, Debrégeas H, Kippenberg TJ, Brès CS.   +7 more
europepmc   +3 more sources

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi. [PDF]

PLOS Glob Public Health, 2023
Porter Erlank C, Ali G, Birhanu F, Stanley M, Chirwa JS, Kachale F, Gunda A.   +6 more
europepmc   +3 more sources

Evaluation of outcomes for patients with nitrous oxide-related myeloneuropathy treated with self-injection of hydroxocobalamin versus nurse-led injections on an ambulatory care pathway. [PDF]

BMJ Neurol Open
Hashi M, Smith L, Patyjewicz M, Onen B, Mamigo K, Adu-Poku E, Fox G, Noyce AJ.   +7 more
europepmc   +3 more sources

Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China. [PDF]

Patient Prefer Adherence, 2022
Wei Y, Zhao J, Ming J, Zhang X, Chen Y.
europepmc   +3 more sources